Lv7
3530 积分 2021-07-29 加入
Architects of immunity: How dendritic cells shape CD8 + T cell fate in cancer
9天前
已完结
The parallel lives of angiogenesis and immunosuppression: cancer and other tales
11天前
已完结
VEGF suppresses T‐lymphocyte infiltration in the tumor microenvironment through inhibition of NF‐κB‐induced endothelial activation
11天前
已完结
Generation, secretion and degradation of cancer immunotherapy target PD-L1
12天前
已完结
Targeted protein degradation for cancer therapy
12天前
已完结
Advancing targeted protein degradation for cancer therapy
12天前
已完结
Protocol to isolate and enrich mouse splenic naive CD4+ T cells for in vitro CD4+CD8αα+ cell induction
14天前
已完结
Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial
15天前
已完结
Mutual ATRaction: Assessing Synergy of Berzosertib with Sacituzumab Govitecan
15天前
已完结
Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer
17天前
已完结
皖公网安备34019202002308
